Back to News
Market Impact: 0.3

Compared to Estimates, Veeva (VEEV) Q3 Earnings: A Look at Key Metrics

VEEV
Corporate EarningsCompany FundamentalsAnalyst EstimatesAnalyst InsightsHealthcare & BiotechInvestor Sentiment & Positioning
Compared to Estimates, Veeva (VEEV) Q3 Earnings: A Look at Key Metrics

Veeva reported fiscal Q3 (Oct) revenue of $811.24m, up 16% year‑over‑year, and EPS of $2.04 versus $1.75 a year ago, beating Zacks consensus revenue and EPS estimates by 2.4% and 4.6% respectively. Subscription revenue was $682.5m (+17.5% YoY) with a strong subscription gross margin of 86.6% (above estimates), while professional services gross margin slipped to 29.8% (below estimates); both R&D and Commercial segments posted beats with double‑digit subscription growth. The stock has underperformed recently (‑5.8% over the past month) and carries a Zacks Rank #3 (Hold), signaling that the quarter confirms durable recurring‑revenue growth but mixed margin trends may keep near‑term performance in line with the market.

Analysis

For the quarter ended October 2025 Veeva reported revenue of $811.24 million, up 16% year‑over‑year, and GAAP EPS of $2.04 versus $1.75 a year ago; both top‑line and EPS modestly beat Zacks consensus (revenue beat +2.44%, EPS beat +4.62%). Subscription revenue was $682.5 million (+17.5% YoY) and subscription non‑GAAP gross margin was 86.6% (above the 85.9% analyst estimate), indicating continued strength in high‑margin recurring sales. Professional services and other revenue of $128.74 million beat estimates but professional‑services gross margin slipped to 29.8% versus the 31.8% estimate, signaling margin pressure in the lower‑margin services mix that could depress aggregate margins if the mix persists. R&D and Commercial subscription lines both delivered double‑digit subscription growth (R&D subscription $364.85 million +20.6% YoY; Commercial subscription $317.65 million +14.1% YoY), supporting the recurring‑revenue thesis. Shares have underperformed the S&P 500 over the past month (‑5.8%) and the stock carries a Zacks Rank #3 (Hold), reflecting the market’s view that growth is intact but near‑term upside may be capped by margin and execution risk; key near‑term catalysts to monitor are management guidance, subscription retention, and whether professional‑services margins recover.

AllMind AI Terminal